List of works - Paul C J Armstrong

An Activation-Specific Platelet Inhibitor That Can Be Turned On/Off by Medically Used Hypothermia

scientific article published on 09 June 2011

Antiplatelet actions of statins and fibrates are mediated by PPARs

scientific article published on 15 January 2009

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2

scholarly article by Serena Lucotti et al published 25 March 2019 in Journal of Clinical Investigation

Association of MicroRNAs and YRNAs With Platelet Function

scientific article published on 08 December 2015

Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy.

scientific article

Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?

scientific article published on November 2010

Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)

scientific article published on 19 April 2018

Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs

scientific article published on 9 December 2014

GPIIb/IIIa inhibitors: from bench to bedside and back to bench again.

scientific article published on 28 February 2012

GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors

scientific article

Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage

scientific article published on 12 August 2019

Inhibition of profibrotic microRNA-21 affects platelets and their releasate

scientific article published on 02 November 2018

Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity

scientific article published on 23 November 2021

Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies.

scientific article

Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice

scientific article

Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction

scientific article

Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing

scientific article published on 02 August 2011

P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation

scientific article

Platelet responses to pharmacological and physiological interventions in middle-aged men with different habitual physical activity levels.

scientific article published on 3 January 2018

Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography

scientific article published on 03 March 2015

Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach

scientific article

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

scientific article published on 01 October 2015

The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.

scientific article published in March 2016

Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse

scientific article

Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness

scientific article published in October 2009

List of works by Paul C J Armstrong

An Activation-Specific Platelet Inhibitor That Can Be Turned On/Off by Medically Used Hypothermia

Antiplatelet actions of statins and fibrates are mediated by PPARs

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2

Association of MicroRNAs and YRNAs With Platelet Function

Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy.

Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?

Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)

Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs

GPIIb/IIIa inhibitors: from bench to bedside and back to bench again.

GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors

Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage

Inhibition of profibrotic microRNA-21 affects platelets and their releasate

Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity

Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies.

Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice

Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction

Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing

P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation

Platelet responses to pharmacological and physiological interventions in middle-aged men with different habitual physical activity levels.

Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography

Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.

Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse

Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness